MiRNA-424 facilitates diabetic nephropathy progression through targeting RICTOR both in diabetic nephropathy rat models and high-glucose–induced glomerular mesangial cell models (Wang et al., 2019). Here, RICTOR is linked to diabetic kidney disease.